| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,540 | 0,570 | 22:10 | |
| 0,530 | 0,575 | 21:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:46 | Schlaadt: Partnerschaft mit Zentek zur Entwicklung kreislauffähiger Verpackungslösungen | 1 | plasticker | ||
| ZENTEK Aktie jetzt für 0€ handeln | |||||
| Mo | Zentek Ltd. - 6-K, Report of foreign issuer | 5 | SEC Filings | ||
| Mo | Zentek Ltd.: Zentek Provides PDAC 2026 Update - Government and First Nations Engagement | 785 | ACCESS Newswire | Company advances Albany Graphite relationships across federal, provincial, and community levels GUELPH, ON / ACCESS Newswire / March 9, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company")... ► Artikel lesen | |
| 04.03. | Zentek Ltd: Zentek begins pilot with Quality Filters on HVAC media | 2 | Stockwatch | ||
| 04.03. | Zentek begins pilot program with U.S. air filter manufacturer | 2 | Investing.com | ||
| 04.03. | Zentek Ltd.: Zentek Announces Pilot Evaluation Program with Quality Filters Inc. | 572 | ACCESS Newswire | GUELPH, ON / ACCESS Newswire / March 4, 2026 / Zentek Ltd. ("Zentek" or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) is pleased to announce the initiation of a pilot evaluation program with Quality Filters... ► Artikel lesen | |
| 26.02. | Zentek advances Albany Graphite project toward feasibility study | 1 | Investing.com | ||
| 26.02. | Zentek forciert Machbarkeitsstudie für Graphitprojekt Albany | 1 | Investing.com Deutsch | ||
| 26.02. | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.02. | Zentek Ltd.: Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment | 1.246 | ACCESS Newswire | Albany Graphite uniquely positioned at intersection of NATO, federal, and provincial critical minerals mandates; Company accelerating path to Pre-Feasibility Study GUELPH, ON / ACCESS Newswire / February... ► Artikel lesen | |
| 26.02. | Zentek Ltd: Zentek has until Aug. 24 to regain compliance on Nasdaq | 5 | Stockwatch | ||
| 26.02. | Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement | 602 | ACCESS Newswire | GUELPH, ON / ACCESS Newswire / February 25, 2026 / Zentek Ltd. ("Zentek"or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted... ► Artikel lesen | |
| 17.02. | Zentek outlines strategic shift, focusing on Albany Graphite project | 1 | Investing.com | ||
| 17.02. | Zentek Ltd.: Zentek Provides Strategic and Regulatory Update | 840 | ACCESS Newswire | GUELPH, ON / ACCESS Newswire / February 17, 2026 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) and (OTC:ZENYF), further to its letter to shareholders dated January 29, 2026, wishes... ► Artikel lesen | |
| 15.02. | Zenyatta Trainer John Shirreffs Will Be Remembered And Missed | 2 | Forbes | ||
| 30.01. | Zentek Ltd: Zentek CEO issues letter to shareholders | 1 | Stockwatch | ||
| 29.01. | Zentek Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.01. | Zentek announces strategic reset to focus on three core platforms | 1 | Investing.com | ||
| 29.01. | Zentek Ltd.: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan | 494 | Newsfile | Guelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a... ► Artikel lesen | |
| 06.01. | Zentek Ltd: Zentek's Albany graphite clears nuclear-grade tests | 3 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,280 | -2,23 % | Vorläufige Umsatzzahlen für 2025 bei Formycon und 'Anpassungen'der Prognose | Die Formycon AG erwartet für 2025 Konzernumsatzerlöse von ca. 45 Mio. EUR, muss jedoch ihre Prognose neu zubereiten. Auf Basis vorläufiger und noch nicht testierter Zahlen rechnet die Formycon (Aktie:... ► Artikel lesen | |
| KOPIN | 1,900 | -2,56 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| RIBER | 5,730 | -2,22 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| ONTO INNOVATION | 159,00 | -4,79 % | ONTO INNOVATION INC. - 10-K, Annual Report | ||
| VEECO INSTRUMENTS | 27,400 | 0,00 % | Veeco Instruments Inc. (VECO) Announces Placement of Orders for Multiple Lumina Metal Organic Chemical Vapor Deposition Systems and Spector Ion Beam Sputtering Optical Coating Systems | ||
| NVE | 58,50 | -3,31 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| SOLESENCE | 1,015 | -1,46 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NANOVIRICIDES | 1,000 | -1,96 % | NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete | SHELTON, CT / ACCESS Newswire / March 11, 2026 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot... ► Artikel lesen | |
| CANATU | 8,360 | +13,90 % | Canatu Oyj: Canatu receives follow-on purchase order for long lead-time items from an existing CNT100 SEMI reactor customer | Canatu Plc Press release 3 March 2026 at 9:05 a.m. EET
Canatu receives follow-on purchase order for long lead-time items from an existing CNT100 SEMI reactor customer
Canatu Plc, a deep technology company... ► Artikel lesen | |
| DOTZ NANO | 0,020 | 0,00 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| GAUZY | 0,508 | +1,72 % | GAUZY LTD: Gauzy Announces Initiation of a Call for Public Tenders for Buyers or Investors | TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announces the initiation... ► Artikel lesen | |
| NANOLOGICA | 0,008 | -6,98 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026 | Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded... ► Artikel lesen | |
| OBDUCAT | 0,003 | -46,88 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen | |
| ACACIA RESEARCH | 4,220 | +20,57 % | Acacia Research signals $2M annualized cost savings from Deflecto plant consolidation while maintaining $340M cash and securities | ||
| ADVANCE ZINCTEK | 0,540 | +2,86 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.02.2026 | Das Instrument OYS US68162K1060 OLYMPIC STEEL EQUITY wird cum Kapitalmassnahme gehandelt am 16.02.2026 und ex Kapitalmassnahme am 17.02.2026 The instrument OYS US68162K1060 OLYMPIC STEEL EQUITY is traded... ► Artikel lesen |